◼ Archived
World
🔮 holds ✗
Roche
10 independently sourced, verified news trends involving Roche.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 3 news categories, from Jul 2, 2026 through Oct 27, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Business
🔮 fades ✓
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug
◼ Archived
Business
🔮 holds ✗
Roche builds blockbuster BTK case for fenebrutinib in multiple sclerosis as FDA decision approaches
◼ Archived
Business
🔮 holds ✗
Roche returns to China’s Hansoh for $15B biobucks ADC pact
◼ Archived
Business
🔮 holds ✗
Roche inks $1.2B deal with China's Rona to enter emerging ALK7 obesity race
◼ Archived
Business
🔮 fades ✓
Roche Halts Development of Obesity Drug Candidate
◼ Archived
Business
🔮 holds ✗
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
◼ Archived
Business
🔮 holds ✗
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial
◼ Archived
Health
🔮 holds ✓
New Alzheimer’s drug could stop disease
Emerging Alzheimer’s drug candidates are generating global attention as researchers and health advocates evaluate their potential to stop the disease.
◼ Archived
Business
🔮 holds ✗
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Roche's drug candidate divarasib outperformed rival therapies in a Phase 3 trial for KRAS-driven lung cancer.